-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Eli Lilly, Raises Price Target to $1430

Benzinga·10/07/2026 14:33:02
Diffusion vocale
Morgan Stanley analyst Terence Flynn maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1419 to $1430.